214 related articles for article (PubMed ID: 36461099)
21. Characterization of the primate TRIM gene family reveals the recent evolution in primates.
Qiu S; Liu H; Jian Z; Fan Z; Liu S; Xing J; Li J
Mol Genet Genomics; 2020 Sep; 295(5):1281-1294. PubMed ID: 32564135
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers.
Vu T; Fowler A; McCarty N
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568609
[TBL] [Abstract][Full Text] [Related]
23. To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.
Hage A; Rajsbaum R
J Gen Virol; 2019 Dec; 100(12):1641-1662. PubMed ID: 31661051
[TBL] [Abstract][Full Text] [Related]
24. Origin and diversification of TRIM ubiquitin ligases.
Marín I
PLoS One; 2012; 7(11):e50030. PubMed ID: 23185523
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
Front Immunol; 2022; 13():998266. PubMed ID: 36248785
[TBL] [Abstract][Full Text] [Related]
26. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D; Zhang Y; Xia Y; Cheng F
Front Oncol; 2022; 12():840410. PubMed ID: 35371994
[TBL] [Abstract][Full Text] [Related]
27. To TRIM the Immunity: From Innate to Adaptive Immunity.
Yang W; Gu Z; Zhang H; Hu H
Front Immunol; 2020; 11():02157. PubMed ID: 33117334
[TBL] [Abstract][Full Text] [Related]
28. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis.
Zhou M; Ouyang J; Zhang G; Zhu X
BMC Pulm Med; 2022 Dec; 22(1):467. PubMed ID: 36474231
[TBL] [Abstract][Full Text] [Related]
30. The roles and targeting options of TRIM family proteins in tumor.
Zhang Y; Zhang W; Zheng L; Guo Q
Front Pharmacol; 2022; 13():999380. PubMed ID: 36249749
[TBL] [Abstract][Full Text] [Related]
31. It's a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease.
Dudley-Fraser J; Rittinger K
Front Mol Neurosci; 2023; 16():1287257. PubMed ID: 38115822
[TBL] [Abstract][Full Text] [Related]
32. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
[TBL] [Abstract][Full Text] [Related]
33. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.
Rajsbaum R; García-Sastre A; Versteeg GA
J Mol Biol; 2014 Mar; 426(6):1265-84. PubMed ID: 24333484
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma.
Dai W; Wang J; Wang Z; Xiao Y; Li J; Hong L; Pei M; Zhang J; Yang P; Wu X; Tang W; Jiang X; Jiang P; Xiang L; Li A; Lin J; Liu S; Wang J
Front Oncol; 2021; 11():767644. PubMed ID: 35004288
[TBL] [Abstract][Full Text] [Related]
35. The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members.
Mandell MA; Saha B; Thompson TA
Front Pharmacol; 2020; 11():308. PubMed ID: 32226386
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling of the TRIM protein family reveals potential biomarkers for indicating tuberculosis status.
Chen Y; Cao S; Sun Y; Li C
Microb Pathog; 2018 Jan; 114():385-392. PubMed ID: 29225091
[TBL] [Abstract][Full Text] [Related]
37. Tripartite-motif proteins and innate immune regulation.
McNab FW; Rajsbaum R; Stoye JP; O'Garra A
Curr Opin Immunol; 2011 Feb; 23(1):46-56. PubMed ID: 21131187
[TBL] [Abstract][Full Text] [Related]
38. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
39. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties.
Sardiello M; Cairo S; Fontanella B; Ballabio A; Meroni G
BMC Evol Biol; 2008 Aug; 8():225. PubMed ID: 18673550
[TBL] [Abstract][Full Text] [Related]
40. Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma.
Wu G; Xu Y; Li L; Li J; Ruan N; Dong J; Si Z; Xia Q; Wang Q
Int J Med Sci; 2020; 17(18):2905-2916. PubMed ID: 33173411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
